Ablaze Pharma
CEP Certificates (EDQM COS List)

Ablaze Pharma

CEP Database

Certificates of Suitability to the European Pharmacopoeia (CEP), issued by the EDQM.

TSE United States
  • Total Records 1
  • Latest End Date -
  • Data Source EDQM
  • Last Updated 2024-08-20
Company Overview

Company

Ablaze Pharma

Country

China

Social Profiles

Company Snapshot

Ablaze Pharma

Room 122, 3rd Floor, No. 696, Weihai Road, Shanghai

China

www.ablazepharma.com/ info@ablazepharma.com View on Map
CEP Records Timeline (1 record)
2024
20 Aug
TSE Valid

Product

Glutaraldehyde fixed bovine pericardium

Substance

ABBOTT MEDICAL St. Paul US

Certificate No.

CEP 2015-381 - Rev 02

Substance No.

.

Issue Date

2024-08-20

End Date

-

United States

Country

United States

Identifiers

Certificate No.: CEP 2015-381 - Rev 02
Substance No.: .

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    1 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
Official Source

All data is sourced from the official EDQM CEP database (Certification of Suitability to the European Pharmacopoeia).

Visit EDQM
Record Details Preview

Click "View Details" on any record above to expand full details inline.

Country

United States

Identifiers

Certificate No.: CEP 2015-381 - Rev 02
Substance No.: .

100% Official Data

Directly from the EDQM CEP database

Regular Updates

Data updated regularly from official sources

Trusted by Professionals

100K+ pharma professionals worldwide

Secure & Reliable

Enterprise-grade security and data protection

CEP data is obtained from the official EDQM (European Directorate for the Quality of Medicines) database.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.